MDCM
PFE icon

Morgan Dempsey Capital Management’s Pfizer PFE Stock Holding History

Morgan Dempsey Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9K Sell
496
-2,444
-83% -$65.1K 0.01% 110
2025
Q4 		$73.2K Sell
2,940
-163,496
-98% -$4.12M 0.04% 79
2025
Q3 		$4.24M Sell
166,436
-27,835
-14% -$687K 1.88% 29
2025
Q2 		$4.71M Sell
194,271
-2,146
-1% -$50K 1.97% 26
2025
Q1 		$4.98M Buy
196,417
+13,393
+7% +$350K 2.07% 30
2024
Q4 		$4.86M Sell
183,024
-53,023
-22% -$1.44M 1.95% 30
2024
Q3 		$6.83M Sell
236,047
-26,174
-10% -$764K 2.34% 27
2024
Q2 		$7.34M Sell
262,221
-5,801
-2% -$160K 2.45% 24
2024
Q1 		$7.44M Sell
268,022
-14,355
-5% -$398K 2.38% 28
2023
Q4 		$8.13M Buy
282,377
+25,791
+10% +$780K 2.49% 29
2023
Q3 		$8.51M Buy
256,586
+5,389
+2% +$191K 2.65% 21
2023
Q2 		$9.21M Buy
251,197
+42,129
+20% +$1.64M 2.63% 20
2023
Q1 		$8.53M Sell
209,068
-239
-0.1% -$10.3K 2.31% 29
2022
Q4 		$10.7M Buy
209,307
+6,461
+3% +$310K 2.97% 9
2022
Q3 		$8.88M Buy
202,846
+602
+0.3% +$29.3K 2.92% 10
2022
Q2 		$10.6M Buy
202,244
+5,597
+3% +$285K 3.23% 3
2022
Q1 		$10.2M Sell
196,647
-3,443
-2% -$179K 3.02% 9
2021
Q4 		$11.8M Sell
200,090
-7,670
-4% -$380K 3.68% 3
2021
Q3 		$8.94M Sell
207,760
-11,131
-5% -$493K 2.94% 13
2021
Q2 		$8.57M Sell
218,891
-7,701
-3% -$299K 2.69% 22
2021
Q1 		$8.21M Buy
226,592
+37,282
+20% +$1.32M 2.59% 24
2020
Q4 		$6.97M Sell
189,310
-52,061
-22% -$1.91M 2.83% 19
2020
Q3 		$8.4M Buy
241,371
+8,916
+4% +$313K 3.22% 10
2020
Q2 		$7.21M Buy
232,455
+14,798
+7% +$503K 2.95% 19
2020
Q1 		$6.74M Buy
217,657
+59,302
+37% +$2.02M 3.26% 14
2019
Q4 		$5.89M Buy
158,355
+4,279
+3% +$152K 2.35% 27
2019
Q3 		$5.25M Buy
154,076
+9,236
+6% +$336K 1.93% 29
2019
Q2 		$5.95M Buy
144,840
+71,008
+96% +$2.82M 2.24% 20
2019
Q1 		$2.98M Buy
73,832
+1,502
+2% +$60.2K 1.18% 36
2018
Q4 		$3M Buy
72,330
+312
+0.4% +$13K 1.31% 37
2018
Q3 		$3.01M Sell
72,018
-1,881
-3% -$72.4K 1.16% 39
2018
Q2 		$2.54M Buy
73,899
+1,073
+1% +$36.7K 1.01% 39
2018
Q1 		$2.45M Buy
+72,826
New +$2.5M 0.96% 39
2016
Q3 		– Sell
-70
Closed -$2K – 191
2016
Q2 		$2K Buy
+70
New +$2.23K ﹤0.01% 189
2015
Q4 		– Sell
-233
Closed -$7K – 189
2015
Q3 		$7K Buy
+233
New +$7.47K ﹤0.01% 159

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgan Dempsey Capital Management's PFE Position: Q1 2026 in Review

Morgan Dempsey Capital Management reduced its Pfizer (PFE) stake by 83% in Q1 2026, selling an estimated $65.1K and leaving 496 shares worth $13.9K. The position accounts for 0.01% of the portfolio, ranked #110.

Morgan Dempsey Capital Management first reported a position in PFE in Q3 2015 and has held it in 35 quarters since. The position peaked at $11.8M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Morgan Dempsey Capital Management held 496 shares of Pfizer worth $13.9K as of Q1 2026.
  • Morgan Dempsey Capital Management sold 2,444 Pfizer shares in Q1 2026, an estimated $65.1K.
  • Pfizer made up 0.01% of Morgan Dempsey Capital Management's portfolio in Q1 2026, its #110 holding.
  • Morgan Dempsey Capital Management first reported a position in Pfizer in Q3 2015 and has held it in 35 quarters since.
  • Morgan Dempsey Capital Management's Pfizer position peaked at $11.8M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Morgan Dempsey Capital Management's 13F filing for Q1 2026, filed 6 May 2026.